# ImpactLife – FDA Inspection, Aug 26, 2022

Source: https://www.keypedia.com/records/fda_inspections/impactlife/6e7055e0-3337-47c1-999c-408097818f9b
Source feed: FDA_Inspections

> FDA inspection 1178326 of ImpactLife, August 26, 2022. Classification: No Action Indicated (NAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1178326
- Company Name: ImpactLife
- Inspection Date: 2022-08-26
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1022638 - 2017-07-11
- FDA Inspection 919931 - 2015-03-17
- [FDA Inspection 828388 - 2013-04-22](https://www.keypedia.com/records/fda_inspections/impactlife/c9816c9f-d243-4e3c-a7ab-4fbd04f3cc6f)
- FDA Inspection 694631 - 2010-10-21

Company: https://www.keypedia.com/companies/impactlife/3e3ace68-2277-4814-b18e-e7801ac17174

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d